Method for treating pain in trigeminal neuralgia

Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S019300, C530S331000

Reexamination Certificate

active

07820857

ABSTRACT:
The present invention is directed to the use of a class of peptide compounds for treating pain in trigeminal neuralgia.

REFERENCES:
patent: 5378729 (1995-01-01), Kohn et al.
patent: 5585358 (1996-12-01), Bialer et al.
patent: 5760038 (1998-06-01), Murugesan et al.
patent: 5773475 (1998-06-01), Kohn
patent: 5885999 (1999-03-01), Elliott et al.
patent: 6001876 (1999-12-01), Singh
patent: 6037324 (2000-03-01), Schwender et al.
patent: 6083941 (2000-07-01), Farb
patent: 6083951 (2000-07-01), Bradbury
patent: 6114390 (2000-09-01), Engel et al.
patent: 6277825 (2001-08-01), Olivera et al.
patent: 6331637 (2001-12-01), Chan et al.
patent: 6492553 (2002-12-01), Hulme et al.
patent: 6727226 (2004-04-01), Olivera et al.
patent: 6737408 (2004-05-01), Balasubramanium et al.
patent: 6803481 (2004-10-01), Selve
patent: 6884910 (2005-04-01), Harris
patent: 7416864 (2008-08-01), Stoehr
patent: 2002/0052418 (2002-05-01), Shirvan et al.
patent: 2002/0169174 (2002-11-01), Chackalamannil et al.
patent: 2003/0216466 (2003-11-01), Scheuerman et al.
patent: 2004/0101582 (2004-05-01), Wolicki
patent: 2004/0204495 (2004-10-01), Shirvan et al.
patent: 2004/0220077 (2004-11-01), Selve
patent: 2005/0209163 (2005-09-01), Stoehr
patent: 2005/0227961 (2005-10-01), Kucharik et al.
patent: 2005/0288234 (2005-12-01), Stoehr
patent: 2006/0046957 (2006-03-01), Beyreuther et al.
patent: 2006/0100157 (2006-05-01), Rauschkolb-Loffler et al.
patent: 2006/0135437 (2006-06-01), Stoehr et al.
patent: 2006/0252749 (2006-11-01), Stohr
patent: 2007/0042969 (2007-02-01), Rauschkolb-Loffler et al.
patent: 2007/0043120 (2007-02-01), Beyreuther et al.
patent: 2007/0048372 (2007-03-01), Beyreuther et al.
patent: 2007/0054962 (2007-03-01), Selve
patent: 2007/0197657 (2007-08-01), Beyreuther et al.
patent: 2008/0027137 (2008-01-01), Riedner et al.
patent: 2008/0287545 (2008-11-01), Scheller et al.
patent: 2009/0018197 (2009-01-01), Rudd et al.
patent: 2009/0018198 (2009-01-01), Stohr
patent: 0 555 537 (1993-08-01), None
patent: 0 885 186 (1998-12-01), None
patent: 0 997 147 (2000-05-01), None
patent: 1 077 945 (2001-02-01), None
patent: 1 160 248 (2001-12-01), None
patent: 1 243 263 (2002-09-01), None
patent: 1 486 205 (2004-12-01), None
patent: 1 486 206 (2004-12-01), None
patent: 1 537 862 (2005-06-01), None
patent: 1 541 138 (2005-06-01), None
patent: 1 579 858 (2005-09-01), None
patent: 1 688 137 (2006-08-01), None
patent: WO 96/32100 (1996-10-01), None
patent: WO 99/07413 (1999-02-01), None
patent: WO 99/56761 (1999-11-01), None
patent: WO 00/00463 (2000-01-01), None
patent: WO 00/21509 (2000-04-01), None
patent: WO 00/51586 (2000-09-01), None
patent: WO 01/17976 (2001-03-01), None
patent: WO 01/78762 (2001-10-01), None
patent: WO 02/13766 (2002-02-01), None
patent: WO 02/15922 (2002-02-01), None
patent: WO 02/24698 (2002-03-01), None
patent: WO 02/42256 (2002-05-01), None
patent: WO 02/50051 (2002-06-01), None
patent: WO 02/060863 (2002-08-01), None
patent: WO 02/074297 (2002-09-01), None
patent: WO 02/074784 (2002-09-01), None
patent: WO 02/076979 (2002-10-01), None
patent: WO 03/000642 (2003-01-01), None
patent: WO 03/106482 (2003-12-01), None
patent: WO 2004/043926 (2004-05-01), None
patent: WO 2004/066987 (2004-08-01), None
patent: WO 2004/066990 (2004-08-01), None
patent: WO 2004/100871 (2004-11-01), None
patent: WO 2005/040355 (2005-05-01), None
patent: WO 2005/053667 (2005-06-01), None
patent: WO 2005/092313 (2005-10-01), None
patent: WO 2005/099740 (2005-10-01), None
patent: WO 2005/120539 (2005-12-01), None
Lowry, Thomas (Mechanism and Theory in Organic Chemistry, pp. 60-70, Harper & Row, New York, 1976).
Vos B. P. (The Journal of Neuroscience : the Official Journal of the Society for Neuroscience 14(5) Pt 1, pp. 2708-2723, 1994).
Abstract of WO 03/039520, May 2003.
Benoist et al. (1999)Exp. Brain Res. 126:383-398.
Abdulla & Smith (2002) J. Neurophysiol. 88:2518-2529.
Akiba et al. (2003) Receptors & Channels 9:291-299.
Amir et al. (2006) J. Pain 7(5 Suppl. 3):S1-S29.
Arnér & Meyerson (1988) Pain 33:11-23.
Arroyo (2003) “Safety of SPM 927 in subjects with epilepsy and neuropathic pain” Poster presented at AES Scientific Exhibit, Dec. 5-10, 2003.
Backonja (2002) Neurology 59:S14-S17.
Backonja (2003) Anesth. Analg. 97:785-790.
Béguin et al. (2003) Bioorganic & Medicinal Chemistry 11:4275-4285.
Béguin et al. (2004) Bioorganic & Medicinal Chemistry 12:3079-3096.
Bennett & Xie (1988) Pain 33(1):87-107 (abstract only http://www.ncbi.nlm.nih.gov/pubmed/2837713).
Bennett et al. (2000) Pain 86:163-175.
Beyak et al. (2004) Am. J. Physiol. Gastrointest. Liver Physiol. 287:G845-G855.
Beyreuther (2004) “Pharmacology of SPM 927 and its relevance to clinical practice for neuropathic pain” Presented at Visiongain Pain Management, 2004.
Beyreuther et al. (2004) “SPM 927 displays potent antinococeptive effects in rat models for inflammatory and neuropathic pain” Poster presented at Neuropathic Pain, May 13-14, 2004.
Beyreuther et al. (2006) “Effects of lacosamide as compared to other analgesics: a responder analysis in the streptozotocin rat model for diabetic neuropathic pain” Poster 618 presented at American Pain Society, 2006 (abstract at http://www.ampainsoc.org/db2/abstract/view?poster—id=2637#618).
Beyreuther et al. (2007) CNS Drug Rev. 13(1):21-42.
Beyreuther et al. (2007) Arthritis Res. Therapy 9:R14, http://arthritis-research.com/content/9/1/R14.
Bialer et al. (2002) Epilepsy Res. 51:31-71.
Biton et al. (2003) Epilepsia 44(Suppl. 9):259, abst. 2.241 (poster attached).
Blackburn-Munro et al. (2002) Eur. J. Pharmacol. 445:231-238.
Bretschneider et al. (2006) http://www.ampainsoc.org/db2/abstract/view?poster—id=2765#766.
Cawello et al. (2003) Epilepsia 44(Suppl. 9):95, abst. 1.265 (poster attached).
Cawello et al. (2004) Epilepsia 45(Suppl. 7):307, abst. 2.342 (poster attached).
Chevrier et al. (2004) Br. J. Pharmacol. 142:576-584.
Chipkin (2005) Am. J. Med. 118(5A):4S-13S.
Cummins et al. (2004) J. Neurosci. 24(38):8232-8236.
Decosterd & Woolf (2000) Pain 87:149-158.
Doty et al. (2004) in Bialer et al., Epilepsy Res. 61:1-48, pp. 14-16.
Doty et al. (2004) “Update on the clinical development of SPM 927 (formerly harkoseride)” Presented at EILAT VII, May 2004.
Dowdall et al. (2005) Pharmacol. Biochem. Behavior 80:93-108.
Dubuisson & Dennis (1977) Pain 4:161-174.
Duncan & Kohn (2005) Epilepsy Res. 67:81-87.
Eller et al. (2005) Neurosurg. Focus 18(5):E3, 3 pp.
Elliott (1997) Brain Res. 754:221-226.
Erichsen & Blackburn-Munro (2002) Pain 98:151-161.
Everill et al. (2001) Neurosci. 106(1):161-169.
Field et al. (1997) Br. J. Pharmacol. 121:1513-1522.
Field et al. (2002) J. Pharmacol. Exp. Ther. 303(2):730-735.
Freynhagen et al. (2005) Pain 115:254-263.
Hama et al. (1999) Pharmacol. Biochem. Behavior 62:67-74.
Han et al. (2000) Pain 84:253-261.
Hao et al. (2004) “SPM 927, a new anti-epileptic drug, alleviates neuropathic pain-like behaviors in rats after spinal cord or trigeminal nerve injury” Poster presented at Neuropathic Pain—Changing Paradigms in Diagnosis and Treatment, Madrid, May 2004.
Hidvegi et al. (2006) “Lacosamide in subjects with painful distal diabetic neuropathy: results of a multi-center, open-label, follow-on trial” Poster presented at American Pain Society, May 3-6, 2006.
Hofmann et al. (2003) Eur. J. Pharmacol. 470:17-25.
Hong et al. (2004) J. Biol. Chem. 279(28):29341-29350.
Honore et al. (2000) Neurosci. 98(3):585-598.
Horstmann et al. (2002) Epilepsia 43(Suppl. 7):188, abst. 2.174 (poster attached).
Horstmann et al. (2003) Epilepsia 44(Suppl. 9):97, Abst. 1.271 (poster attached).
Horstmann et al. (2003) “SPM 927 does not prolong the QTc interval” Poster presented at 6th International Conference on the Mechanisms and Treatment of Neuropathic Pain, San Francisco, Sep. 18-20, 2003.
Hovinga (2003) IDrugs 6(5):479-485.
Hunt (2003) Clin. Orthopaedics Rel. Res. 409:96-105.
Hurley et al. (2002) Anesthesiology 97:1263-12

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for treating pain in trigeminal neuralgia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating pain in trigeminal neuralgia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating pain in trigeminal neuralgia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4205352

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.